Innovations by Ideas - Introduction to the call

t

EIT Health is supported by the EIT, a body of the European Union

Innovation ProjectsThe Innovation by Ideas Call

2016-02-02

2

Innovation Update•Portfolio 2016

•What have we learned?

•Innovation by Ideas projects in BP17

•Process & Important dates

3

Portfolio 2016

• IbD Projects: COOK2HEALTH; CLOSE; FACET; P3-Stroke; PAPHOS; PersoCo; VITALITY; WARM-APP

• IbI Projects: Active Hands; AVC; D-Brain; DeTecT2D; GRACE-AGE; Hand-Tech; I4PCM; JIGSAW-E; KIS2.0; MACH; MiniQ; MULTI-MODE; Osteo-Life; Patient miner; RareCancer

• Total budget for Innovation projects: ca. 9.3 M Euro

4

Portfolio Spread

Lifesty

le Inter

vention

Self M

anag

emen

t of H

ealth

Workplac

e Inter

ventions

Overco

mming Functional

Loss

Impro

ving H

ealth

care S

ystem

s

Treati

ng and M

anag

ing Chro

nic Dise

ase

Motivate

Active Pers

onal

Metabolic

Health

Ageing w

ith a

helathy b

rain

Mobility a

nd Indep

enden

ce Th

roughout L

ife

Personali

zed Oncology

and in

tegrat

ed Can

cer Care

Susta

inable

Continuum of Care

to Su

pport Acti

ve Liv

ing in Eu

rope0

24

6

810

12

Number of Projects

5

Number of Projects

2016 2017 2018

Total EIT H Budget (M)

30 (21) 45 60

# IbI 14 (15) 28

# IbD 7 (8) 14

6

BP 16 - What Have we Learned?•Too much secrecy is a problem!

•Active portfolio management is needed• Look at effects beyond current BP

•The EIT likes to review!• EIT hires its own experts

•Working with Word and Excel is not the way to go!

•Final budget is not revealed until very late (December!)

•EIT expects revisions at short notice…

7

BP 16 - What Have we Learned II?

• External reviewers seen as positive, hearings process less so

• Enforced budget cuts 10% is not something we should put into routine practice

• Relative weaknesses in project portfolio• Lack of links to Accelerator and Campus activities

• Knowledge triangle integration• More like H2020 in some cases

• Business case needs to be sharpened

t

EIT Health is supported by the EIT, a body of the European Union

Innovation by Ideas BP17

9

Updates for IbI ProjectsInnovation by Ideas•Changes:

• Maximum 500 K Euro EIT KAVA per project• Funding for maximum of 12 months

• EIT KAVA must be used by end of 2017

•Stays the same:• Partners from at least 2 CLCs need to be involved• No thematic focus other than EIT Health’s strategic objectives• Can be led by any core or associate partner• At least one academic, and one non-academic partner

10

Innovation Projects BP 2017

•Increased focus on:• Business & market case (market size, competition etc.)

• Involvement of Accelerator • Knowledge triangle integration

• Campus & Accelerator• Innovation output (product, service etc.)

•Increased emphasis on hearings • to evaluate projects• To build portfolio

11

Areas for IbI Projects

Support Active Ageing

Workplace interventions

Overcoming functional loss

Optimise the physical working environment

Improve Healthcare

Improving healthcare systems

Treating and managing chronic diseases

Establish holistic care solutions in home and

clinical settings

Promote Healthy Living

Enable people to take charge of their own

health

Lifestyle intervention

Self-management of health

ExamplesBusiness Objectives

12

Process for BP17 for Innovation Projects: Timings

•Call openings• IbI February 1st

• IbD April 1st

•Call closing• May 16th

• Eligibility check 17-20 May

•External review period: 23 May – 17 June

•Hearings: 29/6 – 1/7 & 11-15/7 July

13

Increased Focus on Innovation / Market

4. Innovation and Market 1. Innovative outputs (1200 characters; Describe the innovation output(s) of the project (products and

services))

2. Estimated market size (500 characters; Estimate market size, both economically in Euro and number of potential patients / consumers)

3. Market introduction strategy (1750 characters; Describe how product(s) / service(s) will be introduced onto market, what additional steps need to be taken, how this will be achieved)

4. Self assessments:1. TRL Before and after project (750 characters; Provide a short explanation around the TRL before /

after the project)2. Time to market (estimated launch year for innovations specified) (750 characters)3. SWOT (2000 characters)4. Technological risk (750 characters; Describe the major technical risk(s) to the project)5. Commercial risk (750 characters; Describe the major commercial risk(s) to the project) 

14

Knowledge Triangle Integration

Innovation

CampusAccelerator

15

Knowledge Triangle IntegrationExamples

Innovation

CampusAccelerator

Living Labs / Test-beds

Market experts

BC support

16

Innovation

CampusAccelerator

MOOC support

Living Labs / Test-beds

Market experts

BC support

Knowledge Triangle IntegrationExamples

Integrated executive education

17

Innovation

CampusAccelerator

Business ideas for incubation

LL/TB cases

Knowledge Triangle IntegrationExamples

18

Innovation

CampusAccelerator

Business ideas for incubation

LL/TB cases

Knowledge Triangle IntegrationExamples

Business cases for students

Projects as learning environments

19

Integrated Innovation Projects

Business ideas for incubation / evaluation

Innovation evaluation in LL / TB

Education of end-users & purchasers

Students as practitioners

Market evaluation Outreach

REPRESENTATIVES FOR CAMPUS & ACCELERATOR ARE HERE!

20

Evaluation and Hearings• Projects evaluated and ranked by 3 independent

external reviewers

• Highest ranked projects invited to hearings• Ca 1 hour per project• Mixture of presentation and Q&A

• Portfolio for 2017 to be built from projects invited to hearings, plus existing projects

21

Planned Process to BP17

IbI

IbD

Legacy projects

Hearings

1 Feb 1 Apr 16 May

External Reviews

29 Jun – 1Jul & 11-15 Jul

Building portfolio

8 Aug

Communication

Final Revisions

Data for BP ready22 Aug

eit.europa.eu

EIT Health is supported by the EIT, a body of the European Union

Questions